Tenaya Therapeutics Stock Quote TNYA - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

4.18

Bid

3.50

Ask

4.26

Volume

0.00 Day's Range 0.00

1.66 52 Week Range 8.0914

Market Cap

286.747M

Previous Close

4.18

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

389,880

Shares Outstanding

68,111,019

Dividend Yield

PE Ratio

-2.31

Earnings Per Share (EPS)

-1.82

Revenue

Net Profit

-124.08M

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and p... Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.tenayatherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Tenaya Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TNYA. The last closing price for Tenaya Therapeutics was $4.18. Over the last year, Tenaya Therapeutics shares have traded in a share price range of $ 1.66 to $ 8.0914.

Tenaya Therapeutics currently has 68,111,019 shares outstanding. The market capitalization of Tenaya Therapeutics is $286.75 million. Tenaya Therapeutics has a price to earnings ratio (PE ratio) of -2.31.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Initial Data from Ongoing MyPEAK™-1 Phase 1b of TN-201 Expected in Second Half of 2024 Clinical Sites Activated for RIDGE™-1 Phase 1b Clinical Trial of TN-401 Announced Cost Containment Measures...

Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting

SOUTH SAN FRANCISCO, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.22	-5	4.4	4.6	3.94	332818	4.22216361	CS
4	-0.54	-11.4406779661	4.72	4.96	3.81	323539	4.34877869	CS
12	-2.29	-35.3941267388	6.47	6.78	3.81	389880	4.6813918	CS
26	2.28	120	1.9	7.01	1.84	480415	4.48700956	CS
52	-2.88	-40.7932011331	7.06	8.0914	1.66	418436	4.30169834	CS
156	-15.32	-78.5641025641	19.5	32	1.64	317969	6.20520554	CS
260	-15.32	-78.5641025641	19.5	32	1.64	317969	6.20520554	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AAGRAfrican Agriculture Holdings Inc	$ 0.3825 (0.00%)	214
AADRAdvisorShares Dorsey Wright ADR ETF	$ 64.81 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.735 (0.00%)	361
AACIArmada Acquisition Corporation I	$ 11.49 (0.00%)	1k
AACGATA Creativity Global	$ 0.90 (0.00%)	7
AAGRAfrican Agriculture Holdings Inc	$ 0.3825 (0.00%)	214
AADRAdvisorShares Dorsey Wright ADR ETF	$ 64.81 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.735 (0.00%)	361
AACIArmada Acquisition Corporation I	$ 11.49 (0.00%)	1k
AACGATA Creativity Global	$ 0.90 (0.00%)	7
GWAVGreenwave Technology Solutions Inc	$ 0.042 (0.00%)	50.67M
NVOSNovo Integrated Sciences Inc	$ 0.451 (0.00%)	42.39M
CRKNCrown Electrokinetics Corporation	$ 0.1135 (0.00%)	32.27M
FFIEFaraday Future Intelligent Electric Inc	$ 0.5653 (0.00%)	28.85M
HLTHCue Health Inc	$ 0.0725 (0.00%)	25.74M